Luteolin Bioavailability Enhanced by P-Glycoprotein Inhibiti
2026-06-11
This study introduces a luteolin-loaded self-microemulsifying system (Luteolin-SME) that dramatically increases oral bioavailability by inhibiting P-glycoprotein efflux. The findings provide a technical advance for improving absorption of poorly soluble bioactives, with implications for pharmaceutical and nutraceutical development.
TAK-715 and the Dual-Action Revolution in p38α MAPK Research
2026-06-10
Explore how TAK-715, a highly selective p38 MAPK inhibitor, is redefining translational inflammation research by harnessing dual-action mechanisms—simultaneously blocking kinase activity and accelerating dephosphorylation. This article integrates mechanistic insight with strategic guidance, offering a roadmap for advanced cytokine signaling and chronic inflammatory disease studies.
Liproxstatin-1: Precision Ferroptosis Inhibitor for Research
2026-06-10
Liproxstatin-1 enables researchers to dissect ferroptosis with nanomolar precision, offering reproducible, selective inhibition of lipid peroxidation in advanced disease models. Discover optimized workflows, troubleshooting strategies, and unique assay advantages that distinguish Liproxstatin-1 from other ferroptosis inhibitors.
PKM2 Inhibitor (Compound 3k): Precision Targeting in Cancer
2026-06-09
PKM2 inhibitor (compound 3k) empowers researchers to disrupt aerobic glycolysis selectively in tumor cells, enabling advanced studies in cancer metabolism and immune modulation. Its validated selectivity, robust antiproliferative activity, and translational relevance make it a premier tool for both in vitro and in vivo applications.
Presynaptic α2-Adrenergic Modulation of Equine Airway Contra
2026-06-09
This study elucidates how α2-adrenergic receptor stimulation inhibits cholinergic nerve-mediated contractions in equine distal airways, with tolazoline reversing this effect. The findings clarify presynaptic mechanisms in airway smooth muscle regulation and inform in vitro pharmacological research design.
N1-Methyl-Pseudouridine-5'-Triphosphate in Advanced mRNA Syn
2026-06-08
N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) is pivotal for boosting RNA stability and translational efficiency in modern mRNA workflows. Explore how this APExBIO reagent enables robust mRNA vaccine development, supports precision in vitro transcription, and solves common stability challenges in RNA-based research.
Poly-Arginine MIP Sensor Enables Ultra-Trace Dimetridazole D
2026-06-08
This study reports the development of a highly sensitive poly-arginine-based molecularly imprinted polymer (MIP) electrochemical sensor for selective detection of dimetridazole (1,2-Dimethyl-5-nitroimidazole). The innovation offers a simple, low-cost, and ultrasensitive approach to monitoring dimetridazole residues in food matrices, with practical implications for public health and laboratory assay sensitivity.
AI-10-49: Advancing Precision in CBFβ-SMMHC-Targeted Leukemi
2026-06-07
Explore how AI-10-49, a selective CBFβ-SMMHC inhibitor, transforms acute myeloid leukemia research by enabling functional restoration of RUNX1 and dissecting N-MYC/eIF4G1-driven survival pathways. This article delivers a technical edge for researchers seeking robust, mechanism-based tools.
MRT68921: ULK1 Kinase Inhibitor for Precision Autophagy Cont
2026-06-06
MRT68921 stands out as a dual ULK1/2 kinase inhibitor, delivering nanomolar potency and selectivity for dissecting autophagy signaling in preclinical models. This article unpacks optimized workflows, troubleshooting strategies, and actionable protocol enhancements—empowering researchers to achieve reliable autophagy inhibition and high-content mechanistic insights.
Baicalin Methyl Ester: Optimizing Intestinal Barrier Assays
2026-06-05
Baicalin methyl ester, a precision esterified derivative of baicalin, offers researchers a robust tool for dissecting intestinal inflammation and barrier protection in both in vitro and in vivo models. This guide delivers experimental workflow insights, protocol optimizations, and practical troubleshooting advice to maximize reliable, reproducible outcomes in LPS-induced intestinal barrier damage research.
Heart–Insula Axis in PTSD: Insights from Isoproterenol Model
2026-06-05
This study reveals that sympathetic cardiac overactivation, modeled by isoproterenol administration, drives hyperactivity in the insular cortex and induces PTSD-like behaviors in mice. Vagal transmission was identified as the critical pathway mediating this heart-brain axis, with propranolol able to reverse these neurobehavioral changes, highlighting new mechanistic and therapeutic targets for PTSD research.
PDHA1 Succinylation Alters Immunometabolism in Cholangiocarc
2026-06-04
The referenced study uncovers how succinylation of PDHA1 at lysine 83 in cholangiocarcinoma leads to alpha-ketoglutaric acid build-up, impairing macrophage antigen presentation and contributing to immune evasion. These insights reveal a novel metabolic-immune axis underlying chemotherapy resistance and suggest new therapeutic avenues targeting metabolic enzyme post-translational modifications.
FPR2/ALX Agonist Modulates Microglia to Limit CNS Autoimmuni
2026-06-04
This study reveals that activating FPR2/ALX with Quin-C1 modulates microglia and NK cells to reduce neuroinflammation and demyelination in a mouse model of autoimmune astrocytopathy. By dissecting the SYK-AKT-dependent mechanism, the work suggests new immunomodulatory strategies for diseases such as neuromyelitis optica spectrum disorder (NMOSD).
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn
2026-06-03
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents proteolytic degradation during protein extraction and analysis workflows, especially where divalent cation compatibility is required. It should be used in protocols such as Western blot, co-immunoprecipitation, and kinase assays, but is not suitable where EDTA-based chelation is necessary.
Butylated Hydroxyanisole (BHA): Optimizing Oxidative Stress
2026-06-03
Butylated hydroxyanisole (BHA) from APExBIO delivers high-purity antioxidant performance for oxidative stress and ROS modulation assays. This guide details practical workflows, protocol parameters, and troubleshooting strategies, empowering researchers to harness BHA’s unique properties in advanced cellular and disease models.
466 records 16/32 page Previous Next First page 上5页 1617181920 下5页 Last page